Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2021-02-05

FDA Approved: KLONOPIN — Supplemental Application (H2-Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for KLONOPIN (clonazepam) from H2-Pharma, LLC, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KLONOPIN (clonazepam)

Snippet

SUPPL AP for KLONOPIN (CLONAZEPAM)